KittyCara的个人主页 - 老虎社区

KittyCara

暂无个人介绍

IP属地：未知

32关注

0粉丝

0主题

0勋章

2021-05-03

Like and comment please? Thank you!

抱歉，原内容已删除

2021-04-27

So sad

抱歉，原内容已删除

2021-04-27

Hello like and comment please?

What to watch in the markets this week

2021-04-25

Reply please? Thank you

抱歉，原内容已删除

2021-04-25

Oh boo

Wall Street Is Giving Up on These 3 Stocks, and That's a Huge Mistake

2021-04-24

Reply and like please? Thank you

抱歉，原内容已删除

2021-04-15

Oh no! Like and reply please?

抱歉，原内容已删除

2021-04-13

Please respond, thank you!

抱歉，原内容已删除

2021-04-13

Yes!

抱歉，原内容已删除

2021-04-13

Wow cool!

Magna Shares Spike, Company Reported To Be "Very Near" EV Contract With Apple

2021-04-13

[呆住]

5 Value Stocks With 26% to 50% Upside, According to Wall Street

2021-04-13

Noted

Don’t ‘overinterpret’ decision to pause J&J Covid vaccine over rare clotting issue, Dr. Scott Gottlieb says

2021-04-13

[微笑]

5 Value Stocks With 26% to 50% Upside, According to Wall Street

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3579093685551005,"uuid":"3579093685551005","gmtCreate":1615999774355,"gmtModify":1706620612238,"name":"KittyCara","pinyin":"kittycara","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":32,"tweetSize":13,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":108619990,"gmtCreate":1620017455610,"gmtModify":1634208479867,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Like and comment please? Thank you!","listText":"Like and comment please? Thank you!","text":"Like and comment please? Thank you!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/108619990","repostId":"2132853599","repostType":4,"isVote":1,"tweetType":1,"viewCount":305,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":377824605,"gmtCreate":1619516646907,"gmtModify":1634212128796,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"So sad&nbsp;","listText":"So sad&nbsp;","text":"So sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/377824605","repostId":"1152045902","repostType":4,"isVote":1,"tweetType":1,"viewCount":59,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":377377185,"gmtCreate":1619501450147,"gmtModify":1634212227015,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Hello like and comment please?&nbsp;","listText":"Hello like and comment please?&nbsp;","text":"Hello like and comment please?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/377377185","repostId":"1184404050","repostType":4,"repost":{"id":"1184404050","pubTimestamp":1619319329,"share":"https://www.laohu8.com/m/news/1184404050?lang=&edition=full","pubTime":"2021-04-25 10:55","market":"us","language":"en","title":"What to watch in the markets this week","url":"https://stock-news.laohu8.com/highlight/detail?id=1184404050","media":"CNBC","summary":"The last week of April will be extremely busy for markets with a third of the S&P 500 reporting earnings, a Federal Reserve meeting, and new spending and tax proposals from the White House.Big Tech is a highlight of the earnings calendar, with Apple, Microsoft, Amazon, Facebook and Alphabet all releasing results.The Fed is not expected to take any action, but economists expect it to defend its policy to let inflation run hot.There is some key data including first-quarter gross domestic product a","content":"<div>\n<p>KEY POINTSThe last week of April will be extremely busy for markets with a third of the S&P 500 reporting earnings, a Federal Reserve meeting, and new spending and tax proposals from the White House....</p>\n\n<a href=\"https://www.cnbc.com/2021/04/23/taxes-and-inflation-will-be-key-themes-for-markets-in-the-week-ahead.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What to watch in the markets this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat to watch in the markets this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 10:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/04/23/taxes-and-inflation-will-be-key-themes-for-markets-in-the-week-ahead.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe last week of April will be extremely busy for markets with a third of the S&P 500 reporting earnings, a Federal Reserve meeting, and new spending and tax proposals from the White House....</p>\n\n<a href=\"https://www.cnbc.com/2021/04/23/taxes-and-inflation-will-be-key-themes-for-markets-in-the-week-ahead.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","GOOG":"谷歌","TSLA":"特斯拉","GOOGL":"谷歌A",".DJI":"道琼斯","AMZN":"亚马逊",".IXIC":"NASDAQ Composite","AAPL":"苹果"},"source_url":"https://www.cnbc.com/2021/04/23/taxes-and-inflation-will-be-key-themes-for-markets-in-the-week-ahead.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1184404050","content_text":"KEY POINTSThe last week of April will be extremely busy for markets with a third of the S&P 500 reporting earnings, a Federal Reserve meeting, and new spending and tax proposals from the White House.Big Tech is a highlight of the earnings calendar, with Apple, Microsoft, Amazon, Facebook and Alphabet all releasing results.The Fed is not expected to take any action, but economists expect it to defend its policy to let inflation run hot.There is some key data including first-quarter gross domestic product and the Fed’s favorite inflation measure: the personal consumption expenditures deflator.The final week of April is going to be a busy one for markets with a Federal Reserve meeting and a deluge of earnings news.Hot topics in markets will continue to be inflation and taxes.President Joe Biden is expected to detail his “American Families Plan” and the tax increases to pay for it, including a much higher capital gains tax for the wealthy.The plan is the second part of his Build Back Better agenda and will include new spending proposals aimed at helping families. The president addresses a joint session of Congress Wednesday evening.It’s a huge week for earnings with about a third of the S&P 500 reporting, including Big Tech names, such as Apple,Microsoft,Alphabet and Amazon.As many have already done, firms like Boeing, Ford,Caterpillar and McDonald’s, are likely to detail cost pressures they are facing from rising materials and transportation costs and supply chain disruptions.At the same time, the Fed is expected to defend its policy of letting inflation run hot, while assuring markets it sees the pick-up in prices as only temporary. The central bank meets on Tuesday and Wednesday.The central bank takes the main stage“I think the Fed would like not to be a feature next week, but the Fed will be forced from the background because of concerns about inflation,” said Diane Swonk, chief economist at Grant Thornton.The central bank is not expected to make any policy moves, but Fed Chairman Jerome Powell’s press briefing following the meeting Wednesday will be closely watched.So far, the barrage of earnings news has been positive, with 86% of companies reporting earnings beats. Corporate profits are expected to be up about 33.9% for the first quarter, based on estimates and actual reports, according to Refinitiv. Revenues are about 9.9% higher.There is important inflation data Friday when the Fed’s preferred inflation gauge is reported.The personal consumption expenditure report is expected to show a 1.8% rise in core inflation, still below the Fed’s target of 2%. Other data releases include the first-quarter gross domestic product on Thursday, which is expected to have grown by 6.5%, according to Dow Jones.“I think the Fed has no urgency to shift monetary policy at this point,” said Ian Lyngen, head of U.S. rates strategy at BMO. “The Fed needs to acknowledge that the data is improving. We had a strong first quarter.”“The Fed needs to acknowledge that but at the same time they’re keeping extremely accommodative policy in place, so they’ll have to make a note to the fact that the easy policy is warranted,” he said.Lyngen said the Fed will likely point to continued concerns about the pandemic globally as a potential risk to the economic recovery.Powell is also expected to once more explain that the Fed will let inflation rise above its 2% target for a period of time before it raises rates so that the economy can have more time to heal. “It’s going to be a challenge for the Fed,” said Swonk.The base effects for the next several months will make inflation appear to have jumped sharply because of the comparison to a weak period last year. The consumer price index for April could be above 3%, compared to 2.6% last month, Swonk added.“The Fed is trying to let a lot more people get out onto the dance floor before it calls ‘last call,’” she said. “Really what Powell has been saying since day one is if we take care of people on the margins and bring them back into the labor force, the rest will take care of itself.”Stocks were slightly lower in the past week, and Treasury yields held at lower levels. The 10-year yield,which moves opposite price, was at 1.55% Friday.The S&P 500was down 0.1%, ending the week at 4,180, while Nasdaq Composite was down nearly 0.3% at 14,016. The Dow was off just shy of 0.5% at 34,043.Tax hike prospectsStocks were hit hard on Thursday when after a news report said that Biden is expected to propose a capital gains tax rate of 39.6% for people earning more than $1 million a year.Combined with the 3.8% net investment income tax, the new levy would more than double the long term capital gains rate of 20% or the richest Americans.Strategists said Biden is expected to propose raising the income tax rate for those earning more than $400,000.“I think a lot of people are starting to price in the risk there going to be a significant increase in both corporate and capital gains taxes,” said Lyngen.So far, companies have not provided much in the way of commentary on the proposed hike in corporate taxes to 28% from 21% but they have been talking about other costs.David Bianco, chief investment strategist for the Americas at DWS, said he expects larger companies will do better dealing with supply chain constraints than smaller ones. Big Tech is also likely to fare better during the semiconductor shortage than auto makers, which have already announced production shutdowns, he said.“Next week is tech week. I think we’re going to get down on our knees and just be in awe of their business models and their ability to grow at a behemoth scale,” Bianco said.He said he’s not in favor of Wall Street’s popular trade into cyclicals and out of growth. He still favors growth.“We’re overweight equities really because we’re concerned about rising interest rates,” Bianco said. “I’m not bullish in that I expect the market to rise that much from here.”“We stuck with growth and dug deeper into bond substitutes, utilities, staples, real estate,” he said, adding he is underweight industrials, energy and materials. “Energy is doomed. It’s being nationalized via regulation. I do like industrials, they are well-run companies, but I do think infrastructure spending expectations for classic infrastructure are too high.”He also said industrials are good businesses, but the stocks have become overvalued.Bianco said he likes big box stores, but smaller retailers are facing big challenges that were already impacting them prior to Covid. He also finds small biotech firms attractive.“I like healthcare stocks. Those valuations are reasonable. People have been paranoid about politicians beating on them since 1992. They manage through it and lately they’ve been delivering,” he said.Week ahead calendarMondayEarnings:Tesla,Canadian National Railway, Canon,Check Point Software,Otis Worldwide, Vale,Ameriprise,NXP Semiconductor,Albertsons, Royal Phillips8:30 a.m. Durable goodsTuesdayFOMC begins two day meetingEarnings:Microsoft,Alphabet,Visa,Amgen,Advanced Micro Devices,3M,General Electric,Eli Lilly, Hasbro,United Parcel Service,BP,Novartis,JetBlue,Pultegroup,Archer Daniels Midland,Waste Management,Starbucks,Texas Instrument,Chubb,Mondelez,FireEye,Corning,Raytheon9:00 a.m. S&P/Case-Shiller9:00 a.m. FHFA home prices10:00 a.m. Consumer confidence10:00 a.m. Housing vacanciesWednesdayEarnings:Apple, Boeing,Facebook,Qualcomm,Ford,MGM Resorts,Humana,Norfolk Southern,General Dynamics,Boston Scientific, eBay, Samsung Electronics, GlaxoSmithKline,Yum Brands, SiriusXM, Aflac,Cheesecake Factory,Community Health System,CIT Group,Entergy,CME Group,Hess,Ryder System8:30 a.m. Advance economic indicators2:00 p.m. Fed statement2:30 p.m. Fed Chairman Jerome Powell briefingThursdayEarnings:Amazon,Caterpillar,McDonald’s,Twitter,Bristol-Myers Squibb,Comcast,Merck,Northrop Grumman, Airbus,Kraft Heinz,Intercontinental Exchange,Mastercard,Gilead Sciences,U.S. Steel, Cirrus Logic,Texas Roadhouse, Cabot Oil, PG&E,Royal Dutch Shell,Church & Dwight, Carlyle Group,Southern Co.8:30 a.m. Initial jobless claims8:30 a.m. Real GDP Q110:00 a.m. Pending home salesFridayEarnings:ExxonMobil,Chevron,Colgate-Palmolive,AstraZeneca,Clorox,Barclays, AbbVie, BNP Paribas,Weyerhaeuser,Illinois Tool Works, CBOE Global Markets, Lazard,Newell Brands,Aon,LyondellBasell,Pitney Bowes,Phillips 66,Charter Communications8:30 a.m. Personal income and spending8:30 a.m. Employment cost index Q19:45 a.m. Chicago PMI10:00 a.m. Consumer sentimentSaturdayEarnings:Berkshire Hathaway","news_type":1},"isVote":1,"tweetType":1,"viewCount":100,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":375665854,"gmtCreate":1619334234578,"gmtModify":1634274144950,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Reply please? Thank you&nbsp;","listText":"Reply please? Thank you&nbsp;","text":"Reply please? Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/375665854","repostId":"1158817636","repostType":4,"isVote":1,"tweetType":1,"viewCount":157,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":375665070,"gmtCreate":1619334158890,"gmtModify":1634274145189,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Oh boo","listText":"Oh boo","text":"Oh boo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/375665070","repostId":"2129804364","repostType":4,"repost":{"id":"2129804364","pubTimestamp":1619329400,"share":"https://www.laohu8.com/m/news/2129804364?lang=&edition=full","pubTime":"2021-04-25 13:43","market":"us","language":"en","title":"Wall Street Is Giving Up on These 3 Stocks, and That's a Huge Mistake","url":"https://stock-news.laohu8.com/highlight/detail?id=2129804364","media":"Motley Fool","summary":"Conventional wisdom has concocted reasons to abandon these investments, but in each case, the market is missing the bigger picture.","content":"<p>Stock market indexes like the <b>S&amp;P 500</b> and the <b>Nasdaq</b> are trading within about 2% of all-time highs as of this writing. But just because the market averages remain strong, that doesn't mean everything is doing well. In fact, many stocks trade well below their 52-week highs, including <b><a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video Communications</b> (NASDAQ:ZM), <b>Peloton Interactive</b> (NASDAQ:PTON), and <b>Magnite</b> (NASDAQ:MGNI).</p>\n<p>All three of these stocks were big winners in 2020, up 396%, 434%, and 276%, respectively. As we'll see, there are good reasons to buy and hold these past winners, but all three companies are down around 40% from their 52-week highs as investors abandon their long-term theses. Here's why giving up on these stocks so soon is a big mistake.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5dabb0b68fe32e12c1462accee7e973b\" tg-width=\"700\" tg-height=\"474\"><span>Image source: Zoom Video Communications.</span></p>\n<h2><b>But we're getting back to normal!</b></h2>\n<p>In 2020, Zoom enabled people to continue their social and work lives even as they physically distanced themselves to prevent the spread of the coronavirus. But the situation is rapidly changing. Half of the U.S adult population has now received a dose of a coronavirus vaccine, and about a quarter is already fully vaccinated.</p>\n<p>Investors fear that the once ubiquitous Zoom call will be an afterthought in a post-pandemic world. But the company's management doesn't see it that way. Sure, it doesn't anticipate matching its 326% annual revenue growth from 2020,&nbsp;but Zoom is still guiding for 42% growth in 2021 -- over $1 billion more in incremental revenue. That's an impressive growth rate for any company, and it's especially impressive on the heels of a historic year. And management gave this guidance fully aware that the world is starting to return to normal.</p>\n<p>Much of management's optimism comes from its Zoom Phone product. Many Zoom video customers have increased their spending to include an overhaul of their infrastructure for voice. Packaging voice and video together makes sense, giving Zoom the upper hand in landing contracts with more of its customers. And as workers return to the office, it increases the likelihood of companies seeing Zoom Phone as a timely and necessary upgrade.</p>\n<p>However, the true wild card for Zoom, in my opinion, is its optionality for the future. It generated $1.4 billion in free cash flow in 2020 and ended 2020 with $4.2 billion in cash and marketable securities, giving it a lot of firepower to pursue other business opportunities in the workplace-management space. Furthermore, management is actively looking for suitable companies to acquire right now, giving Zoom more expansion potential.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ff9670874674cc33173b4f85f8dff5e6\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Peloton Interactive.</span></p>\n<h2><b>But gyms are reopening!</b></h2>\n<p>Similar to investors' misgivings over Zoom, many are giving up on Peloton because brick-and-mortar gyms have a clear path to fully reopening. For example, consider that 90% of <b>Planet Fitness</b> gyms are now open. In short, the home-fitness space had little competition in 2020, but the competition is back.</p>\n<p>Tapping into the wide open market, Peloton doubled its revenue in fiscal 2020 (ended June 30, 2020) to $1.8 billion. On a calendar basis, revenue was up 139% last year. But those who are writing off Peloton are forgetting something important: Its compound annual growth rate for revenue is over 100% since 2017. In other words, fiscal 2020's top-line result wasn't an anomaly.</p>\n<p>Moreover, something important is happening beneath the surface with Peloton. When the company sells a treadmill or stationary bike, it also starts collecting subscription revenue for its interactive content. In fiscal 2020, roughly 20% of total revenue came from its subscription segment -- on par with the previous year. But as this subscription service scales, its profit margin is expanding. Subscription revenue had a 43% gross margin in fiscal 2019. In 2020, it carried a 57% margin.</p>\n<p>Peloton is guiding for at least 123% revenue growth in fiscal 2021 even though gyms are reopening. And its profitability is expanding along with the subscription business. To me, its long-term prospects still look very bright.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/556055ca286d98de498e4f102ac0af63\" tg-width=\"700\" tg-height=\"465\"><span>Image source: Getty Images.</span></p>\n<h2>But there's limited upside!</h2>\n<p>Since its initial public offering, shares of <b>The Trade Desk</b> are up well over 2,000%, making it <a href=\"https://laohu8.com/S/AONE\">one</a> of the biggest market winners over the last five years. In 2020, investors started looking at Magnite as a younger version of The Trade Desk -- an unfortunate comparison leading to unrealistic expectations.</p>\n<p>The Trade Desk is a demand-side ad-tech company, whereas Magnite is the largest independent <i>supply</i>-side ad-tech company. We need both the demand side and supply side, yes. But supply-side players partner with publishers instead of advertisers. And because there are more advertisers than publishers, demand-side players logically have longer growth runways.</p>\n<p>It seems investors are waking up to the more-limited upside for supply-side ad-tech players and are now giving up on Magnite stock. But just because the space is smaller doesn't mean the stock can't beat the market from here.</p>\n<p>According to a recent survey by the Interactive Advertising Bureau, 60% of advertisers plan to shift spending away from linear-TV sources (like cable) and toward connected-TV (CTV) in 2021.&nbsp;And eMarketer expects CTV spending to nearly <i>double</i> in the next two years alone. This undeniable trend equally benefits supply-side companies like Magnite and smaller competitor <b>PubMatic</b>. But being the biggest supply-side player in the space has its advantages as Magnite's recent deal with Innovid illustrates.</p>\n<p>Innovid is a company that's bringing more interactive ads&nbsp;to CTV, and it just announced it's partnering with The Trade Desk and Magnite to increase adoption. Interactive ads can increase consumer engagement, which is a reason advertisers may increasingly pursue this style of CTV ad. And I don't think it's a coincidence Innovid chose Magnite as a partner -- as the biggest players, Magnite and The Trade Desk have scale to increase the project's odds of success. Indeed, Magnite's scale is partly why I consider it a top way to play the CTV trend.</p>\n<h2><b>Don't give up</b></h2>\n<p>Investors shouldn't be contrarian just to be different. But when you have good reason to make a contrarian investment, it can pay off. I believe that's the case with these companies. Zoom, Peloton, and Magnite may have fallen out of favor in recent months, but if they continue to capitalize on their long-term opportunities, Wall Street will eventually come back around to these stocks, rewarding the investors who patiently endured these down times.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street Is Giving Up on These 3 Stocks, and That's a Huge Mistake</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street Is Giving Up on These 3 Stocks, and That's a Huge Mistake\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 13:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/24/wall-street-giving-up-on-3-stocks-huge-mistake/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stock market indexes like the S&P 500 and the Nasdaq are trading within about 2% of all-time highs as of this writing. But just because the market averages remain strong, that doesn't mean everything ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/24/wall-street-giving-up-on-3-stocks-huge-mistake/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTON":"Peloton Interactive, Inc.","MGNI":"Magnite, Inc.","ZM":"Zoom"},"source_url":"https://www.fool.com/investing/2021/04/24/wall-street-giving-up-on-3-stocks-huge-mistake/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2129804364","content_text":"Stock market indexes like the S&P 500 and the Nasdaq are trading within about 2% of all-time highs as of this writing. But just because the market averages remain strong, that doesn't mean everything is doing well. In fact, many stocks trade well below their 52-week highs, including Zoom Video Communications (NASDAQ:ZM), Peloton Interactive (NASDAQ:PTON), and Magnite (NASDAQ:MGNI).\nAll three of these stocks were big winners in 2020, up 396%, 434%, and 276%, respectively. As we'll see, there are good reasons to buy and hold these past winners, but all three companies are down around 40% from their 52-week highs as investors abandon their long-term theses. Here's why giving up on these stocks so soon is a big mistake.\nImage source: Zoom Video Communications.\nBut we're getting back to normal!\nIn 2020, Zoom enabled people to continue their social and work lives even as they physically distanced themselves to prevent the spread of the coronavirus. But the situation is rapidly changing. Half of the U.S adult population has now received a dose of a coronavirus vaccine, and about a quarter is already fully vaccinated.\nInvestors fear that the once ubiquitous Zoom call will be an afterthought in a post-pandemic world. But the company's management doesn't see it that way. Sure, it doesn't anticipate matching its 326% annual revenue growth from 2020, but Zoom is still guiding for 42% growth in 2021 -- over $1 billion more in incremental revenue. That's an impressive growth rate for any company, and it's especially impressive on the heels of a historic year. And management gave this guidance fully aware that the world is starting to return to normal.\nMuch of management's optimism comes from its Zoom Phone product. Many Zoom video customers have increased their spending to include an overhaul of their infrastructure for voice. Packaging voice and video together makes sense, giving Zoom the upper hand in landing contracts with more of its customers. And as workers return to the office, it increases the likelihood of companies seeing Zoom Phone as a timely and necessary upgrade.\nHowever, the true wild card for Zoom, in my opinion, is its optionality for the future. It generated $1.4 billion in free cash flow in 2020 and ended 2020 with $4.2 billion in cash and marketable securities, giving it a lot of firepower to pursue other business opportunities in the workplace-management space. Furthermore, management is actively looking for suitable companies to acquire right now, giving Zoom more expansion potential.\nImage source: Peloton Interactive.\nBut gyms are reopening!\nSimilar to investors' misgivings over Zoom, many are giving up on Peloton because brick-and-mortar gyms have a clear path to fully reopening. For example, consider that 90% of Planet Fitness gyms are now open. In short, the home-fitness space had little competition in 2020, but the competition is back.\nTapping into the wide open market, Peloton doubled its revenue in fiscal 2020 (ended June 30, 2020) to $1.8 billion. On a calendar basis, revenue was up 139% last year. But those who are writing off Peloton are forgetting something important: Its compound annual growth rate for revenue is over 100% since 2017. In other words, fiscal 2020's top-line result wasn't an anomaly.\nMoreover, something important is happening beneath the surface with Peloton. When the company sells a treadmill or stationary bike, it also starts collecting subscription revenue for its interactive content. In fiscal 2020, roughly 20% of total revenue came from its subscription segment -- on par with the previous year. But as this subscription service scales, its profit margin is expanding. Subscription revenue had a 43% gross margin in fiscal 2019. In 2020, it carried a 57% margin.\nPeloton is guiding for at least 123% revenue growth in fiscal 2021 even though gyms are reopening. And its profitability is expanding along with the subscription business. To me, its long-term prospects still look very bright.\nImage source: Getty Images.\nBut there's limited upside!\nSince its initial public offering, shares of The Trade Desk are up well over 2,000%, making it one of the biggest market winners over the last five years. In 2020, investors started looking at Magnite as a younger version of The Trade Desk -- an unfortunate comparison leading to unrealistic expectations.\nThe Trade Desk is a demand-side ad-tech company, whereas Magnite is the largest independent supply-side ad-tech company. We need both the demand side and supply side, yes. But supply-side players partner with publishers instead of advertisers. And because there are more advertisers than publishers, demand-side players logically have longer growth runways.\nIt seems investors are waking up to the more-limited upside for supply-side ad-tech players and are now giving up on Magnite stock. But just because the space is smaller doesn't mean the stock can't beat the market from here.\nAccording to a recent survey by the Interactive Advertising Bureau, 60% of advertisers plan to shift spending away from linear-TV sources (like cable) and toward connected-TV (CTV) in 2021. And eMarketer expects CTV spending to nearly double in the next two years alone. This undeniable trend equally benefits supply-side companies like Magnite and smaller competitor PubMatic. But being the biggest supply-side player in the space has its advantages as Magnite's recent deal with Innovid illustrates.\nInnovid is a company that's bringing more interactive ads to CTV, and it just announced it's partnering with The Trade Desk and Magnite to increase adoption. Interactive ads can increase consumer engagement, which is a reason advertisers may increasingly pursue this style of CTV ad. And I don't think it's a coincidence Innovid chose Magnite as a partner -- as the biggest players, Magnite and The Trade Desk have scale to increase the project's odds of success. Indeed, Magnite's scale is partly why I consider it a top way to play the CTV trend.\nDon't give up\nInvestors shouldn't be contrarian just to be different. But when you have good reason to make a contrarian investment, it can pay off. I believe that's the case with these companies. Zoom, Peloton, and Magnite may have fallen out of favor in recent months, but if they continue to capitalize on their long-term opportunities, Wall Street will eventually come back around to these stocks, rewarding the investors who patiently endured these down times.","news_type":1},"isVote":1,"tweetType":1,"viewCount":235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":372841783,"gmtCreate":1619193743942,"gmtModify":1634287834314,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Reply and like please? Thank you&nbsp;","listText":"Reply and like please? Thank you&nbsp;","text":"Reply and like please? Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/372841783","repostId":"1128911279","repostType":4,"isVote":1,"tweetType":1,"viewCount":137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":347647386,"gmtCreate":1618494988745,"gmtModify":1634292550590,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Oh no! Like and reply please?&nbsp;","listText":"Oh no! Like and reply please?&nbsp;","text":"Oh no! Like and reply please?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/347647386","repostId":"1138925904","repostType":4,"isVote":1,"tweetType":1,"viewCount":325,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345522753,"gmtCreate":1618324786272,"gmtModify":1634293696358,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Please respond, thank you!&nbsp;","listText":"Please respond, thank you!&nbsp;","text":"Please respond, thank you!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/345522753","repostId":"1117691635","repostType":4,"isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345522000,"gmtCreate":1618324736300,"gmtModify":1634293696935,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Yes!&nbsp;","listText":"Yes!&nbsp;","text":"Yes!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/345522000","repostId":"1117691635","repostType":4,"isVote":1,"tweetType":1,"viewCount":84,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345528581,"gmtCreate":1618324702243,"gmtModify":1634293697982,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Wow cool!&nbsp;","listText":"Wow cool!&nbsp;","text":"Wow cool!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/345528581","repostId":"1117691635","repostType":4,"repost":{"id":"1117691635","pubTimestamp":1618324153,"share":"https://www.laohu8.com/m/news/1117691635?lang=&edition=full","pubTime":"2021-04-13 22:29","market":"us","language":"en","title":"Magna Shares Spike, Company Reported To Be \"Very Near\" EV Contract With Apple","url":"https://stock-news.laohu8.com/highlight/detail?id=1117691635","media":"zerohedge","summary":"Shares of Canada-based mobility technology company and OEM Magna are spiking this morning on news th","content":"<p>Shares of Canada-based mobility technology company&nbsp;and OEM Magna are spiking this morning on news that the company's joint venture with LG could be in line to produce Apple's electric vehicles.</p><p>That joint venture&nbsp;&nbsp;is \"very near\" to signing contracts with Apple,The Korea Times reported. Shares were up about 5% in the pre-market session.</p><p><img src=\"https://static.tigerbbs.com/250068103e1d253e9a7d37c1b263667f\" tg-width=\"500\" tg-height=\"260\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/1eaa5932feca6bf89741bca97e7a6b31\" tg-width=\"659\" tg-height=\"564\" referrerpolicy=\"no-referrer\"></p><p><b>\"LG Magna e-Powertrain is very near to signing contracts with Apple under which they could handle the initial volume production of Apple EVs.</b>Contract details are still being discussed,\"the report says. Apple is expected to produce a limited number of first gen EVs to evaluate their marketability.</p><p>\"Because LG Group affiliates including LG Display, LG Chem, LG Energy Solution and LG Innotek are already included in Apple's parts supply chain, Apple doesn't have to worry about any supply chain issues. These LG affiliate are qualified to guarantee production yields and faster delivery of parts needed for Apple EVs,\" a source told the Korea Times.</p><p>\"As the LG brand is not that strong in the global EV industry, it needs a pretty competitive reference to show off its transformation efforts. From that standpoint, LG's bet on the Apple EV is not that bad, and vice versa for Apple,\" a second source said.</p><p>A prototype is expected in early 2024.</p><p>And of course, there's the icing on the cake:</p><p><img src=\"https://static.tigerbbs.com/4d4ad6936cbe254f3bfef70e5f2a1383\" tg-width=\"463\" tg-height=\"429\" referrerpolicy=\"no-referrer\">In addition to Apple, should a contract be signed, Magnaalso sports names&nbsp;BMW, Honda, Hyundai, Volvo, Volkswagen and Toyota, among about 45 others, as OEM customers. To date, the stock has traded with a valuation consistent of other auto manufacturers...</p><p><img src=\"https://static.tigerbbs.com/280daf9bc511996342578e87c18aa49f\" tg-width=\"464\" tg-height=\"323\"></p><p>But could further positioning as an EV name, and a potential contract with arguably the most popular company in the world change that? It looks like the market may think so.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Magna Shares Spike, Company Reported To Be \"Very Near\" EV Contract With Apple</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMagna Shares Spike, Company Reported To Be \"Very Near\" EV Contract With Apple\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-13 22:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/magna-shares-spike-after-korea-times-reports-contract-tie-apple-very-near><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Canada-based mobility technology company and OEM Magna are spiking this morning on news that the company's joint venture with LG could be in line to produce Apple's electric vehicles.That ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/magna-shares-spike-after-korea-times-reports-contract-tie-apple-very-near\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MGA":"曼格纳国际","AAPL":"苹果"},"source_url":"https://www.zerohedge.com/markets/magna-shares-spike-after-korea-times-reports-contract-tie-apple-very-near","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117691635","content_text":"Shares of Canada-based mobility technology company and OEM Magna are spiking this morning on news that the company's joint venture with LG could be in line to produce Apple's electric vehicles.That joint venture  is \"very near\" to signing contracts with Apple,The Korea Times reported. Shares were up about 5% in the pre-market session.\"LG Magna e-Powertrain is very near to signing contracts with Apple under which they could handle the initial volume production of Apple EVs.Contract details are still being discussed,\"the report says. Apple is expected to produce a limited number of first gen EVs to evaluate their marketability.\"Because LG Group affiliates including LG Display, LG Chem, LG Energy Solution and LG Innotek are already included in Apple's parts supply chain, Apple doesn't have to worry about any supply chain issues. These LG affiliate are qualified to guarantee production yields and faster delivery of parts needed for Apple EVs,\" a source told the Korea Times.\"As the LG brand is not that strong in the global EV industry, it needs a pretty competitive reference to show off its transformation efforts. From that standpoint, LG's bet on the Apple EV is not that bad, and vice versa for Apple,\" a second source said.A prototype is expected in early 2024.And of course, there's the icing on the cake:In addition to Apple, should a contract be signed, Magnaalso sports names BMW, Honda, Hyundai, Volvo, Volkswagen and Toyota, among about 45 others, as OEM customers. To date, the stock has traded with a valuation consistent of other auto manufacturers...But could further positioning as an EV name, and a potential contract with arguably the most popular company in the world change that? It looks like the market may think so.","news_type":1},"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345523018,"gmtCreate":1618324616334,"gmtModify":1634293700318,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"[呆住]&nbsp;","listText":"[呆住]&nbsp;","text":"[呆住]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/345523018","repostId":"2127274015","repostType":4,"repost":{"id":"2127274015","pubTimestamp":1618318800,"share":"https://www.laohu8.com/m/news/2127274015?lang=&edition=full","pubTime":"2021-04-13 21:00","market":"us","language":"en","title":"5 Value Stocks With 26% to 50% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2127274015","media":"Motley Fool","summary":"These companies are big-time bargains in the eyes of professional investors.","content":"<p>For more than a decade, everything on Wall Street has revolved around growth stocks. Historically low lending rates and the previous 11-year economic expansion gave fast-paced companies a free pass to romp higher.</p><p>But the guard may be changing.</p><p>Over the very long term (90 years, 1926-2015), value stocks have outperformed growth stocks. What's more, value stocks have historically done particularly well during the early stages of an economic recovery, which is where we are right now.</p><p>According to 12-month consensus price targets from analysts on Wall Street, five value stocks are particularly cheap, with implied upside ranging from 26% to as much as 50%. Even more interesting, these companies all originate from two specific industries: drug development and precious metal mining.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621161%2Ffinancial-newspaper-dollar-sign-stock-quotes-invest-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h3>Vertex Pharmaceuticals: Implied upside of 34%</h3><p>The first thing investors should understand about value stocks is that some of them can be growth stocks, too. This happens to be the case with specialty drug developer <b>Vertex Pharmaceuticals</b> (NASDAQ:VRTX), which is growing annually by a double-digit percentage but has a forward price-to-earnings ratio of just 16. If Wall Street's <a href=\"https://laohu8.com/S/AONE\">one</a>-year price target of almost $285 proves accurate, Vertex offers investors about 34% upside.</p><p>Vertex's claim to fame is its line of successful treatments for cystic fibrosis (CF). CF is a hard-to-treat genetic disease characterized by thick mucus production that can obstruct the pancreas and lungs. Vertex has developed multiple generations of gene-specific treatments, including its latest blockbuster, combination therapy Trikafta. This newest drug applies to about 90% of all CF patients (it targets the most common mutation) and is projected to eventually hit $6 billion in annual sales. For some context, it generated close to $3.9 billion in sales in its first full year on pharmacy shelves in 2020.</p><p>Vertex is also loaded with cash. It ended last year with $6.66 billion in cash, cash equivalents, and marketable securities, which should give it more than enough capital to go shopping for treatments outside the CF space to broaden its revenue channels.</p><p>In short, it's a special company in the biotech space that's not getting nearly enough attention.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621161%2Fgold-bar-ingot-precious-metal-invest-inflation-fear-panic-mining-stock-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"454\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h3>SSR Mining: Implied upside of 37%</h3><p>There might not be an industry packed with more value at the moment than gold. Gold stocks have been cutting costs for the past half-decade. When coupled with a considerably higher gold price, we're left with companies that have high single-digit or low double-digit price-to-earnings ratios and oodles of cash flow.</p><p>In particular, mid-tier mining company <b>SSR Mining</b> (NASDAQ:SSRM) offers an implied upside of 37%, if we assume Wall Street's 12-month price target is correct.</p><p>Why SSR Mining? Last year, SSR completed a merger of equals with Turkey's Alacer Gold. The deal combined SSR's three producing assets (two gold mines and <a href=\"https://laohu8.com/S/AONE.U\">one</a> silver mine) with Alacer's Copler gold mine. This merger effectively doubled estimated output over the next five years to between 700,000 ounces and 800,000 ounces of gold. What's more, free cash flow is estimated to be $450 million annually in 2021 and 2022. That's pretty incredible when you consider that SSR Mining ended 2020 with $457 million in net cash. Net cash positions are somewhat rare in the gold mining space.</p><p>SSR is also valued at between four and five times cash flow per share in 2021. After following the industry for more than a decade, my observation is that a cash flow multiple of 10 often denotes a fair valuation. In other words, this cash flow multiple suggests what Wall Street is already implying: There's luster still to come with SSR.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621161%2Fprescription-drug-pills-stacked-on-hundred-dollar-bill-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h3>Viatris: Implied upside of 50%</h3><p>Now, if you want a value stock that has Wall Street licking its chops, at least based on consensus price target, it's brand-name and generic drug developer <b>Viatris</b> (NASDAQ:VTRS). If the name doesn't ring a bell, it could be because the company was formed from the merger of <b>Pfizer</b>'s Upjohn unit and Mylan in mid-November 2020, and it took on the new name. But it's a name investors might want to know, because Wall Street believes it offers 50% upside.</p><p>Combining Pfizer's established drug unit with a generic drug developer that's been contending with industrywide pricing pressures hasn't gone as planned, thus far. However, Viatris' management sees light at the end of the tunnel. The combined entity should be able to pay down $6.5 billion of its $26 billion in total debt through 2023, and it'll be realizing an estimated $1 billion in annualized cost synergies by 2023.</p><p>Furthermore, Viatris anticipates a return to modest growth in 2024, along with ramped-up investment in research and development. Keep in mind, though, Viatris will be churning out plenty of cash flow this year and every year leading up to, and beyond, 2024. That's the secret sauce that will allow it to pay down its debt, potentially repurchase some of its stock, and parse out a healthy 3% annual yield to shareholders.</p><p>One last thing: It has a consensus price-to-earnings ratio in 2021 (its expected trough year) of under four.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621161%2Fgold-ingot-with-hundred-dollar-bill-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"464\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h3>Barrick Gold: Implied upside of 44%</h3><p>Have I mentioned that gold stocks are a beacon of value? If you prefer your mining companies on the larger side (SSR Mining is a midcap with a $3.4 billion market cap), <b>Barrick Gold</b> (NYSE:GOLD) is the stock to consider. With a consensus price target of $30.48, Wall Street believes Barrick could return 44% to shareholders over the next year.</p><p>Sometimes, size does matter. Barrick's enormous operations helped the company produce 4.76 million gold equivalent ounces (GEO) at an all-in sustaining cost (AISC) of $967 an ounce in 2020. Better yet, investments in underground automation at Kibali and Luolo-Gounkoto should allow these key assets to produce an AISC in the range of $800 to $900 per GEO in 2021. In short, Barrick Gold is fully capable of generating a margin of $800 to $900 per GEO over the physical price of gold. Not surprisingly, Barrick has generated around $4.5 billion in cumulative free cash flow over the previous two years.</p><p>Another interesting thing about Barrick Gold is the company's balance sheet, which has been greatly improved. In just the past eight quarters, the company's roughly $3.6 billion in net debt has turned into a positive net cash position of $33 million. Having this added financial flexibility should allow Barrick Gold to move forward with a number of projects designed to automate or expand output at its core mines.</p><p>Investors can scoop up shares of Barrick for less than seven times Wall Street's projected cash flow per share in 2021 and 2022.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621161%2Flab-research-biotech-dropper-into-test-tube-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h3>Merck: Implied upside of 26%</h3><p>Last, but certainly not least, Wall Street is expecting big things out of pharmaceutical stock and <b>Dow Jones</b> component <b>Merck</b> (NYSE:MRK). Based on where it ended the previous week, analysts are forecasting up to 26% upside for shares of the company over the next year.</p><p>If Merck is to power higher in the months to come, it's probably going to be on the heels of its blockbuster cancer immunotherapy Keytruda, which is approved to treat approximately two dozen types or stages of cancer. The most successful immunotherapy to date brought in $14.4 billion for Merck last year, representing a 30% increase from its 2019 full-year sales.</p><p>Keytruda is also being examined in dozens of additional clinical trials as a monotherapy or combination treatment. Between these label expansion opportunities, improving demand or duration of use in existing indications, and exceptional pricing power, Keytruda has an opportunity to eventually become the world's top-selling drug.</p><p>Beyond drug development, Merck is churning out growth from its animal health division. Sales were up 10% last year, excluding currency movements. There's steady growth potential to be had from developing treatments for companion animals, as well as ensuring the health of farmers' livestock.</p><p>At just over 10 times forward-year earnings, Merck has the look of a bargain.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Value Stocks With 26% to 50% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Value Stocks With 26% to 50% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-13 21:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/13/5-value-stocks-with-26-to-50-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than a decade, everything on Wall Street has revolved around growth stocks. Historically low lending rates and the previous 11-year economic expansion gave fast-paced companies a free pass to...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/13/5-value-stocks-with-26-to-50-upside-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VTRS":"Viatris Inc.","GOLD":"巴里克黄金","VRTX":"福泰制药","SSRM":"SSR Mining Inc","MRK":"默沙东"},"source_url":"https://www.fool.com/investing/2021/04/13/5-value-stocks-with-26-to-50-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2127274015","content_text":"For more than a decade, everything on Wall Street has revolved around growth stocks. Historically low lending rates and the previous 11-year economic expansion gave fast-paced companies a free pass to romp higher.But the guard may be changing.Over the very long term (90 years, 1926-2015), value stocks have outperformed growth stocks. What's more, value stocks have historically done particularly well during the early stages of an economic recovery, which is where we are right now.According to 12-month consensus price targets from analysts on Wall Street, five value stocks are particularly cheap, with implied upside ranging from 26% to as much as 50%. Even more interesting, these companies all originate from two specific industries: drug development and precious metal mining.Image source: Getty Images.Vertex Pharmaceuticals: Implied upside of 34%The first thing investors should understand about value stocks is that some of them can be growth stocks, too. This happens to be the case with specialty drug developer Vertex Pharmaceuticals (NASDAQ:VRTX), which is growing annually by a double-digit percentage but has a forward price-to-earnings ratio of just 16. If Wall Street's one-year price target of almost $285 proves accurate, Vertex offers investors about 34% upside.Vertex's claim to fame is its line of successful treatments for cystic fibrosis (CF). CF is a hard-to-treat genetic disease characterized by thick mucus production that can obstruct the pancreas and lungs. Vertex has developed multiple generations of gene-specific treatments, including its latest blockbuster, combination therapy Trikafta. This newest drug applies to about 90% of all CF patients (it targets the most common mutation) and is projected to eventually hit $6 billion in annual sales. For some context, it generated close to $3.9 billion in sales in its first full year on pharmacy shelves in 2020.Vertex is also loaded with cash. It ended last year with $6.66 billion in cash, cash equivalents, and marketable securities, which should give it more than enough capital to go shopping for treatments outside the CF space to broaden its revenue channels.In short, it's a special company in the biotech space that's not getting nearly enough attention.Image source: Getty Images.SSR Mining: Implied upside of 37%There might not be an industry packed with more value at the moment than gold. Gold stocks have been cutting costs for the past half-decade. When coupled with a considerably higher gold price, we're left with companies that have high single-digit or low double-digit price-to-earnings ratios and oodles of cash flow.In particular, mid-tier mining company SSR Mining (NASDAQ:SSRM) offers an implied upside of 37%, if we assume Wall Street's 12-month price target is correct.Why SSR Mining? Last year, SSR completed a merger of equals with Turkey's Alacer Gold. The deal combined SSR's three producing assets (two gold mines and one silver mine) with Alacer's Copler gold mine. This merger effectively doubled estimated output over the next five years to between 700,000 ounces and 800,000 ounces of gold. What's more, free cash flow is estimated to be $450 million annually in 2021 and 2022. That's pretty incredible when you consider that SSR Mining ended 2020 with $457 million in net cash. Net cash positions are somewhat rare in the gold mining space.SSR is also valued at between four and five times cash flow per share in 2021. After following the industry for more than a decade, my observation is that a cash flow multiple of 10 often denotes a fair valuation. In other words, this cash flow multiple suggests what Wall Street is already implying: There's luster still to come with SSR.Image source: Getty Images.Viatris: Implied upside of 50%Now, if you want a value stock that has Wall Street licking its chops, at least based on consensus price target, it's brand-name and generic drug developer Viatris (NASDAQ:VTRS). If the name doesn't ring a bell, it could be because the company was formed from the merger of Pfizer's Upjohn unit and Mylan in mid-November 2020, and it took on the new name. But it's a name investors might want to know, because Wall Street believes it offers 50% upside.Combining Pfizer's established drug unit with a generic drug developer that's been contending with industrywide pricing pressures hasn't gone as planned, thus far. However, Viatris' management sees light at the end of the tunnel. The combined entity should be able to pay down $6.5 billion of its $26 billion in total debt through 2023, and it'll be realizing an estimated $1 billion in annualized cost synergies by 2023.Furthermore, Viatris anticipates a return to modest growth in 2024, along with ramped-up investment in research and development. Keep in mind, though, Viatris will be churning out plenty of cash flow this year and every year leading up to, and beyond, 2024. That's the secret sauce that will allow it to pay down its debt, potentially repurchase some of its stock, and parse out a healthy 3% annual yield to shareholders.One last thing: It has a consensus price-to-earnings ratio in 2021 (its expected trough year) of under four.Image source: Getty Images.Barrick Gold: Implied upside of 44%Have I mentioned that gold stocks are a beacon of value? If you prefer your mining companies on the larger side (SSR Mining is a midcap with a $3.4 billion market cap), Barrick Gold (NYSE:GOLD) is the stock to consider. With a consensus price target of $30.48, Wall Street believes Barrick could return 44% to shareholders over the next year.Sometimes, size does matter. Barrick's enormous operations helped the company produce 4.76 million gold equivalent ounces (GEO) at an all-in sustaining cost (AISC) of $967 an ounce in 2020. Better yet, investments in underground automation at Kibali and Luolo-Gounkoto should allow these key assets to produce an AISC in the range of $800 to $900 per GEO in 2021. In short, Barrick Gold is fully capable of generating a margin of $800 to $900 per GEO over the physical price of gold. Not surprisingly, Barrick has generated around $4.5 billion in cumulative free cash flow over the previous two years.Another interesting thing about Barrick Gold is the company's balance sheet, which has been greatly improved. In just the past eight quarters, the company's roughly $3.6 billion in net debt has turned into a positive net cash position of $33 million. Having this added financial flexibility should allow Barrick Gold to move forward with a number of projects designed to automate or expand output at its core mines.Investors can scoop up shares of Barrick for less than seven times Wall Street's projected cash flow per share in 2021 and 2022.Image source: Getty Images.Merck: Implied upside of 26%Last, but certainly not least, Wall Street is expecting big things out of pharmaceutical stock and Dow Jones component Merck (NYSE:MRK). Based on where it ended the previous week, analysts are forecasting up to 26% upside for shares of the company over the next year.If Merck is to power higher in the months to come, it's probably going to be on the heels of its blockbuster cancer immunotherapy Keytruda, which is approved to treat approximately two dozen types or stages of cancer. The most successful immunotherapy to date brought in $14.4 billion for Merck last year, representing a 30% increase from its 2019 full-year sales.Keytruda is also being examined in dozens of additional clinical trials as a monotherapy or combination treatment. Between these label expansion opportunities, improving demand or duration of use in existing indications, and exceptional pricing power, Keytruda has an opportunity to eventually become the world's top-selling drug.Beyond drug development, Merck is churning out growth from its animal health division. Sales were up 10% last year, excluding currency movements. There's steady growth potential to be had from developing treatments for companion animals, as well as ensuring the health of farmers' livestock.At just over 10 times forward-year earnings, Merck has the look of a bargain.","news_type":1},"isVote":1,"tweetType":1,"viewCount":548,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":345567990,"gmtCreate":1618324463610,"gmtModify":1634293701996,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/345567990","repostId":"1101919556","repostType":4,"repost":{"id":"1101919556","pubTimestamp":1618320023,"share":"https://www.laohu8.com/m/news/1101919556?lang=&edition=full","pubTime":"2021-04-13 21:20","market":"us","language":"en","title":"Don’t ‘overinterpret’ decision to pause J&J Covid vaccine over rare clotting issue, Dr. Scott Gottlieb says","url":"https://stock-news.laohu8.com/highlight/detail?id=1101919556","media":"cnbc","summary":"KEY POINTS\n\nDr. Scott Gottlieb said Tuesday that people should be “cautious not to overinterpret” th","content":"<div>\n<p>KEY POINTS\n\nDr. Scott Gottlieb said Tuesday that people should be “cautious not to overinterpret” the Food and Drug Administration’s decision to temporarily halt use of Johnson & Johnson’s coronavirus...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/13/scott-gottlieb-cautions-against-overreaction-to-johnson-johnson-covid-vaccine-pause.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Don’t ‘overinterpret’ decision to pause J&J Covid vaccine over rare clotting issue, Dr. Scott Gottlieb says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDon’t ‘overinterpret’ decision to pause J&J Covid vaccine over rare clotting issue, Dr. Scott Gottlieb says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-13 21:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/04/13/scott-gottlieb-cautions-against-overreaction-to-johnson-johnson-covid-vaccine-pause.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nDr. Scott Gottlieb said Tuesday that people should be “cautious not to overinterpret” the Food and Drug Administration’s decision to temporarily halt use of Johnson & Johnson’s coronavirus...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/13/scott-gottlieb-cautions-against-overreaction-to-johnson-johnson-covid-vaccine-pause.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://www.cnbc.com/2021/04/13/scott-gottlieb-cautions-against-overreaction-to-johnson-johnson-covid-vaccine-pause.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1101919556","content_text":"KEY POINTS\n\nDr. Scott Gottlieb said Tuesday that people should be “cautious not to overinterpret” the Food and Drug Administration’s decision to temporarily halt use of Johnson & Johnson’s coronavirus vaccine.\nBut he predicted that the move will nonetheless “fuel the hesitancy” from some people to get a Covid vaccine.\n\nDr. Scott Gottlieb said Tuesday that people should be “cautious not to overinterpret” the Food and Drug Administration’sdecision to temporarily halt useofJohnson & Johnson’s coronavirus vaccine.\n“Let’s start with what the FDA didn’t do,” Gottlieb, the former FDA commissioner and current member of Pfizer’sboard of directors, said on CNBC’s “Squawk Box.” “They didn’t revoke the emergency use authorization. They didn’t order this off the market.”\n“This was a requested pause, which is an awkward regulatory step but I think it reflects the level of caution on their part to not to appear to act too forcefully here,” he said of the decision, which came after six women, out of millions vaccinated, developed blood clots.\nBut Gottlieb predicted that the move will nonetheless “fuel the hesitancy” from some people to get a Covid vaccine.\n“Even if there isn’t a causal relationship, even if this is exceedingly rare, I think we’re going to see that whole conversation now get ignited on social media,” he said.\nThe single-dose vaccine is being paused “out of an abundance of caution” after six women in the U.S. developed a rare blood clotting disorder following their vaccinations, the FDA said Tuesday morning. All of those cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot.\nNearly 7 million doses of J&J’s vaccine have been administered, making the adverse events “extremely rare,” the FDA stressed in a joint statement with the Centers for Disease Control and Prevention.\nGottlieb said that he believes the J&J vaccine could come back into use “with some additional, perhaps, restrictions on its target populations in the interim while they continue to investigate this.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":78,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345564314,"gmtCreate":1618324414838,"gmtModify":1634293702824,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/345564314","repostId":"2127274015","repostType":4,"repost":{"id":"2127274015","pubTimestamp":1618318800,"share":"https://www.laohu8.com/m/news/2127274015?lang=&edition=full","pubTime":"2021-04-13 21:00","market":"us","language":"en","title":"5 Value Stocks With 26% to 50% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2127274015","media":"Motley Fool","summary":"These companies are big-time bargains in the eyes of professional investors.","content":"<p>For more than a decade, everything on Wall Street has revolved around growth stocks. Historically low lending rates and the previous 11-year economic expansion gave fast-paced companies a free pass to romp higher.</p><p>But the guard may be changing.</p><p>Over the very long term (90 years, 1926-2015), value stocks have outperformed growth stocks. What's more, value stocks have historically done particularly well during the early stages of an economic recovery, which is where we are right now.</p><p>According to 12-month consensus price targets from analysts on Wall Street, five value stocks are particularly cheap, with implied upside ranging from 26% to as much as 50%. Even more interesting, these companies all originate from two specific industries: drug development and precious metal mining.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621161%2Ffinancial-newspaper-dollar-sign-stock-quotes-invest-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h3>Vertex Pharmaceuticals: Implied upside of 34%</h3><p>The first thing investors should understand about value stocks is that some of them can be growth stocks, too. This happens to be the case with specialty drug developer <b>Vertex Pharmaceuticals</b> (NASDAQ:VRTX), which is growing annually by a double-digit percentage but has a forward price-to-earnings ratio of just 16. If Wall Street's <a href=\"https://laohu8.com/S/AONE\">one</a>-year price target of almost $285 proves accurate, Vertex offers investors about 34% upside.</p><p>Vertex's claim to fame is its line of successful treatments for cystic fibrosis (CF). CF is a hard-to-treat genetic disease characterized by thick mucus production that can obstruct the pancreas and lungs. Vertex has developed multiple generations of gene-specific treatments, including its latest blockbuster, combination therapy Trikafta. This newest drug applies to about 90% of all CF patients (it targets the most common mutation) and is projected to eventually hit $6 billion in annual sales. For some context, it generated close to $3.9 billion in sales in its first full year on pharmacy shelves in 2020.</p><p>Vertex is also loaded with cash. It ended last year with $6.66 billion in cash, cash equivalents, and marketable securities, which should give it more than enough capital to go shopping for treatments outside the CF space to broaden its revenue channels.</p><p>In short, it's a special company in the biotech space that's not getting nearly enough attention.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621161%2Fgold-bar-ingot-precious-metal-invest-inflation-fear-panic-mining-stock-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"454\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h3>SSR Mining: Implied upside of 37%</h3><p>There might not be an industry packed with more value at the moment than gold. Gold stocks have been cutting costs for the past half-decade. When coupled with a considerably higher gold price, we're left with companies that have high single-digit or low double-digit price-to-earnings ratios and oodles of cash flow.</p><p>In particular, mid-tier mining company <b>SSR Mining</b> (NASDAQ:SSRM) offers an implied upside of 37%, if we assume Wall Street's 12-month price target is correct.</p><p>Why SSR Mining? Last year, SSR completed a merger of equals with Turkey's Alacer Gold. The deal combined SSR's three producing assets (two gold mines and <a href=\"https://laohu8.com/S/AONE.U\">one</a> silver mine) with Alacer's Copler gold mine. This merger effectively doubled estimated output over the next five years to between 700,000 ounces and 800,000 ounces of gold. What's more, free cash flow is estimated to be $450 million annually in 2021 and 2022. That's pretty incredible when you consider that SSR Mining ended 2020 with $457 million in net cash. Net cash positions are somewhat rare in the gold mining space.</p><p>SSR is also valued at between four and five times cash flow per share in 2021. After following the industry for more than a decade, my observation is that a cash flow multiple of 10 often denotes a fair valuation. In other words, this cash flow multiple suggests what Wall Street is already implying: There's luster still to come with SSR.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621161%2Fprescription-drug-pills-stacked-on-hundred-dollar-bill-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h3>Viatris: Implied upside of 50%</h3><p>Now, if you want a value stock that has Wall Street licking its chops, at least based on consensus price target, it's brand-name and generic drug developer <b>Viatris</b> (NASDAQ:VTRS). If the name doesn't ring a bell, it could be because the company was formed from the merger of <b>Pfizer</b>'s Upjohn unit and Mylan in mid-November 2020, and it took on the new name. But it's a name investors might want to know, because Wall Street believes it offers 50% upside.</p><p>Combining Pfizer's established drug unit with a generic drug developer that's been contending with industrywide pricing pressures hasn't gone as planned, thus far. However, Viatris' management sees light at the end of the tunnel. The combined entity should be able to pay down $6.5 billion of its $26 billion in total debt through 2023, and it'll be realizing an estimated $1 billion in annualized cost synergies by 2023.</p><p>Furthermore, Viatris anticipates a return to modest growth in 2024, along with ramped-up investment in research and development. Keep in mind, though, Viatris will be churning out plenty of cash flow this year and every year leading up to, and beyond, 2024. That's the secret sauce that will allow it to pay down its debt, potentially repurchase some of its stock, and parse out a healthy 3% annual yield to shareholders.</p><p>One last thing: It has a consensus price-to-earnings ratio in 2021 (its expected trough year) of under four.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621161%2Fgold-ingot-with-hundred-dollar-bill-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"464\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h3>Barrick Gold: Implied upside of 44%</h3><p>Have I mentioned that gold stocks are a beacon of value? If you prefer your mining companies on the larger side (SSR Mining is a midcap with a $3.4 billion market cap), <b>Barrick Gold</b> (NYSE:GOLD) is the stock to consider. With a consensus price target of $30.48, Wall Street believes Barrick could return 44% to shareholders over the next year.</p><p>Sometimes, size does matter. Barrick's enormous operations helped the company produce 4.76 million gold equivalent ounces (GEO) at an all-in sustaining cost (AISC) of $967 an ounce in 2020. Better yet, investments in underground automation at Kibali and Luolo-Gounkoto should allow these key assets to produce an AISC in the range of $800 to $900 per GEO in 2021. In short, Barrick Gold is fully capable of generating a margin of $800 to $900 per GEO over the physical price of gold. Not surprisingly, Barrick has generated around $4.5 billion in cumulative free cash flow over the previous two years.</p><p>Another interesting thing about Barrick Gold is the company's balance sheet, which has been greatly improved. In just the past eight quarters, the company's roughly $3.6 billion in net debt has turned into a positive net cash position of $33 million. Having this added financial flexibility should allow Barrick Gold to move forward with a number of projects designed to automate or expand output at its core mines.</p><p>Investors can scoop up shares of Barrick for less than seven times Wall Street's projected cash flow per share in 2021 and 2022.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621161%2Flab-research-biotech-dropper-into-test-tube-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h3>Merck: Implied upside of 26%</h3><p>Last, but certainly not least, Wall Street is expecting big things out of pharmaceutical stock and <b>Dow Jones</b> component <b>Merck</b> (NYSE:MRK). Based on where it ended the previous week, analysts are forecasting up to 26% upside for shares of the company over the next year.</p><p>If Merck is to power higher in the months to come, it's probably going to be on the heels of its blockbuster cancer immunotherapy Keytruda, which is approved to treat approximately two dozen types or stages of cancer. The most successful immunotherapy to date brought in $14.4 billion for Merck last year, representing a 30% increase from its 2019 full-year sales.</p><p>Keytruda is also being examined in dozens of additional clinical trials as a monotherapy or combination treatment. Between these label expansion opportunities, improving demand or duration of use in existing indications, and exceptional pricing power, Keytruda has an opportunity to eventually become the world's top-selling drug.</p><p>Beyond drug development, Merck is churning out growth from its animal health division. Sales were up 10% last year, excluding currency movements. There's steady growth potential to be had from developing treatments for companion animals, as well as ensuring the health of farmers' livestock.</p><p>At just over 10 times forward-year earnings, Merck has the look of a bargain.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Value Stocks With 26% to 50% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Value Stocks With 26% to 50% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-13 21:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/13/5-value-stocks-with-26-to-50-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than a decade, everything on Wall Street has revolved around growth stocks. Historically low lending rates and the previous 11-year economic expansion gave fast-paced companies a free pass to...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/13/5-value-stocks-with-26-to-50-upside-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VTRS":"Viatris Inc.","GOLD":"巴里克黄金","VRTX":"福泰制药","SSRM":"SSR Mining Inc","MRK":"默沙东"},"source_url":"https://www.fool.com/investing/2021/04/13/5-value-stocks-with-26-to-50-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2127274015","content_text":"For more than a decade, everything on Wall Street has revolved around growth stocks. Historically low lending rates and the previous 11-year economic expansion gave fast-paced companies a free pass to romp higher.But the guard may be changing.Over the very long term (90 years, 1926-2015), value stocks have outperformed growth stocks. What's more, value stocks have historically done particularly well during the early stages of an economic recovery, which is where we are right now.According to 12-month consensus price targets from analysts on Wall Street, five value stocks are particularly cheap, with implied upside ranging from 26% to as much as 50%. Even more interesting, these companies all originate from two specific industries: drug development and precious metal mining.Image source: Getty Images.Vertex Pharmaceuticals: Implied upside of 34%The first thing investors should understand about value stocks is that some of them can be growth stocks, too. This happens to be the case with specialty drug developer Vertex Pharmaceuticals (NASDAQ:VRTX), which is growing annually by a double-digit percentage but has a forward price-to-earnings ratio of just 16. If Wall Street's one-year price target of almost $285 proves accurate, Vertex offers investors about 34% upside.Vertex's claim to fame is its line of successful treatments for cystic fibrosis (CF). CF is a hard-to-treat genetic disease characterized by thick mucus production that can obstruct the pancreas and lungs. Vertex has developed multiple generations of gene-specific treatments, including its latest blockbuster, combination therapy Trikafta. This newest drug applies to about 90% of all CF patients (it targets the most common mutation) and is projected to eventually hit $6 billion in annual sales. For some context, it generated close to $3.9 billion in sales in its first full year on pharmacy shelves in 2020.Vertex is also loaded with cash. It ended last year with $6.66 billion in cash, cash equivalents, and marketable securities, which should give it more than enough capital to go shopping for treatments outside the CF space to broaden its revenue channels.In short, it's a special company in the biotech space that's not getting nearly enough attention.Image source: Getty Images.SSR Mining: Implied upside of 37%There might not be an industry packed with more value at the moment than gold. Gold stocks have been cutting costs for the past half-decade. When coupled with a considerably higher gold price, we're left with companies that have high single-digit or low double-digit price-to-earnings ratios and oodles of cash flow.In particular, mid-tier mining company SSR Mining (NASDAQ:SSRM) offers an implied upside of 37%, if we assume Wall Street's 12-month price target is correct.Why SSR Mining? Last year, SSR completed a merger of equals with Turkey's Alacer Gold. The deal combined SSR's three producing assets (two gold mines and one silver mine) with Alacer's Copler gold mine. This merger effectively doubled estimated output over the next five years to between 700,000 ounces and 800,000 ounces of gold. What's more, free cash flow is estimated to be $450 million annually in 2021 and 2022. That's pretty incredible when you consider that SSR Mining ended 2020 with $457 million in net cash. Net cash positions are somewhat rare in the gold mining space.SSR is also valued at between four and five times cash flow per share in 2021. After following the industry for more than a decade, my observation is that a cash flow multiple of 10 often denotes a fair valuation. In other words, this cash flow multiple suggests what Wall Street is already implying: There's luster still to come with SSR.Image source: Getty Images.Viatris: Implied upside of 50%Now, if you want a value stock that has Wall Street licking its chops, at least based on consensus price target, it's brand-name and generic drug developer Viatris (NASDAQ:VTRS). If the name doesn't ring a bell, it could be because the company was formed from the merger of Pfizer's Upjohn unit and Mylan in mid-November 2020, and it took on the new name. But it's a name investors might want to know, because Wall Street believes it offers 50% upside.Combining Pfizer's established drug unit with a generic drug developer that's been contending with industrywide pricing pressures hasn't gone as planned, thus far. However, Viatris' management sees light at the end of the tunnel. The combined entity should be able to pay down $6.5 billion of its $26 billion in total debt through 2023, and it'll be realizing an estimated $1 billion in annualized cost synergies by 2023.Furthermore, Viatris anticipates a return to modest growth in 2024, along with ramped-up investment in research and development. Keep in mind, though, Viatris will be churning out plenty of cash flow this year and every year leading up to, and beyond, 2024. That's the secret sauce that will allow it to pay down its debt, potentially repurchase some of its stock, and parse out a healthy 3% annual yield to shareholders.One last thing: It has a consensus price-to-earnings ratio in 2021 (its expected trough year) of under four.Image source: Getty Images.Barrick Gold: Implied upside of 44%Have I mentioned that gold stocks are a beacon of value? If you prefer your mining companies on the larger side (SSR Mining is a midcap with a $3.4 billion market cap), Barrick Gold (NYSE:GOLD) is the stock to consider. With a consensus price target of $30.48, Wall Street believes Barrick could return 44% to shareholders over the next year.Sometimes, size does matter. Barrick's enormous operations helped the company produce 4.76 million gold equivalent ounces (GEO) at an all-in sustaining cost (AISC) of $967 an ounce in 2020. Better yet, investments in underground automation at Kibali and Luolo-Gounkoto should allow these key assets to produce an AISC in the range of $800 to $900 per GEO in 2021. In short, Barrick Gold is fully capable of generating a margin of $800 to $900 per GEO over the physical price of gold. Not surprisingly, Barrick has generated around $4.5 billion in cumulative free cash flow over the previous two years.Another interesting thing about Barrick Gold is the company's balance sheet, which has been greatly improved. In just the past eight quarters, the company's roughly $3.6 billion in net debt has turned into a positive net cash position of $33 million. Having this added financial flexibility should allow Barrick Gold to move forward with a number of projects designed to automate or expand output at its core mines.Investors can scoop up shares of Barrick for less than seven times Wall Street's projected cash flow per share in 2021 and 2022.Image source: Getty Images.Merck: Implied upside of 26%Last, but certainly not least, Wall Street is expecting big things out of pharmaceutical stock and Dow Jones component Merck (NYSE:MRK). Based on where it ended the previous week, analysts are forecasting up to 26% upside for shares of the company over the next year.If Merck is to power higher in the months to come, it's probably going to be on the heels of its blockbuster cancer immunotherapy Keytruda, which is approved to treat approximately two dozen types or stages of cancer. The most successful immunotherapy to date brought in $14.4 billion for Merck last year, representing a 30% increase from its 2019 full-year sales.Keytruda is also being examined in dozens of additional clinical trials as a monotherapy or combination treatment. Between these label expansion opportunities, improving demand or duration of use in existing indications, and exceptional pricing power, Keytruda has an opportunity to eventually become the world's top-selling drug.Beyond drug development, Merck is churning out growth from its animal health division. Sales were up 10% last year, excluding currency movements. There's steady growth potential to be had from developing treatments for companion animals, as well as ensuring the health of farmers' livestock.At just over 10 times forward-year earnings, Merck has the look of a bargain.","news_type":1},"isVote":1,"tweetType":1,"viewCount":435,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":108619990,"gmtCreate":1620017455610,"gmtModify":1634208479867,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Like and comment please? Thank you!","listText":"Like and comment please? Thank you!","text":"Like and comment please? Thank you!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/108619990","repostId":"2132853599","repostType":4,"isVote":1,"tweetType":1,"viewCount":305,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":372841783,"gmtCreate":1619193743942,"gmtModify":1634287834314,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Reply and like please? Thank you&nbsp;","listText":"Reply and like please? Thank you&nbsp;","text":"Reply and like please? Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/372841783","repostId":"1128911279","repostType":4,"isVote":1,"tweetType":1,"viewCount":137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":377377185,"gmtCreate":1619501450147,"gmtModify":1634212227015,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Hello like and comment please?&nbsp;","listText":"Hello like and comment please?&nbsp;","text":"Hello like and comment please?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/377377185","repostId":"1184404050","repostType":4,"repost":{"id":"1184404050","pubTimestamp":1619319329,"share":"https://www.laohu8.com/m/news/1184404050?lang=&edition=full","pubTime":"2021-04-25 10:55","market":"us","language":"en","title":"What to watch in the markets this week","url":"https://stock-news.laohu8.com/highlight/detail?id=1184404050","media":"CNBC","summary":"The last week of April will be extremely busy for markets with a third of the S&P 500 reporting earnings, a Federal Reserve meeting, and new spending and tax proposals from the White House.Big Tech is a highlight of the earnings calendar, with Apple, Microsoft, Amazon, Facebook and Alphabet all releasing results.The Fed is not expected to take any action, but economists expect it to defend its policy to let inflation run hot.There is some key data including first-quarter gross domestic product a","content":"<div>\n<p>KEY POINTSThe last week of April will be extremely busy for markets with a third of the S&P 500 reporting earnings, a Federal Reserve meeting, and new spending and tax proposals from the White House....</p>\n\n<a href=\"https://www.cnbc.com/2021/04/23/taxes-and-inflation-will-be-key-themes-for-markets-in-the-week-ahead.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What to watch in the markets this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat to watch in the markets this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 10:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/04/23/taxes-and-inflation-will-be-key-themes-for-markets-in-the-week-ahead.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe last week of April will be extremely busy for markets with a third of the S&P 500 reporting earnings, a Federal Reserve meeting, and new spending and tax proposals from the White House....</p>\n\n<a href=\"https://www.cnbc.com/2021/04/23/taxes-and-inflation-will-be-key-themes-for-markets-in-the-week-ahead.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","GOOG":"谷歌","TSLA":"特斯拉","GOOGL":"谷歌A",".DJI":"道琼斯","AMZN":"亚马逊",".IXIC":"NASDAQ Composite","AAPL":"苹果"},"source_url":"https://www.cnbc.com/2021/04/23/taxes-and-inflation-will-be-key-themes-for-markets-in-the-week-ahead.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1184404050","content_text":"KEY POINTSThe last week of April will be extremely busy for markets with a third of the S&P 500 reporting earnings, a Federal Reserve meeting, and new spending and tax proposals from the White House.Big Tech is a highlight of the earnings calendar, with Apple, Microsoft, Amazon, Facebook and Alphabet all releasing results.The Fed is not expected to take any action, but economists expect it to defend its policy to let inflation run hot.There is some key data including first-quarter gross domestic product and the Fed’s favorite inflation measure: the personal consumption expenditures deflator.The final week of April is going to be a busy one for markets with a Federal Reserve meeting and a deluge of earnings news.Hot topics in markets will continue to be inflation and taxes.President Joe Biden is expected to detail his “American Families Plan” and the tax increases to pay for it, including a much higher capital gains tax for the wealthy.The plan is the second part of his Build Back Better agenda and will include new spending proposals aimed at helping families. The president addresses a joint session of Congress Wednesday evening.It’s a huge week for earnings with about a third of the S&P 500 reporting, including Big Tech names, such as Apple,Microsoft,Alphabet and Amazon.As many have already done, firms like Boeing, Ford,Caterpillar and McDonald’s, are likely to detail cost pressures they are facing from rising materials and transportation costs and supply chain disruptions.At the same time, the Fed is expected to defend its policy of letting inflation run hot, while assuring markets it sees the pick-up in prices as only temporary. The central bank meets on Tuesday and Wednesday.The central bank takes the main stage“I think the Fed would like not to be a feature next week, but the Fed will be forced from the background because of concerns about inflation,” said Diane Swonk, chief economist at Grant Thornton.The central bank is not expected to make any policy moves, but Fed Chairman Jerome Powell’s press briefing following the meeting Wednesday will be closely watched.So far, the barrage of earnings news has been positive, with 86% of companies reporting earnings beats. Corporate profits are expected to be up about 33.9% for the first quarter, based on estimates and actual reports, according to Refinitiv. Revenues are about 9.9% higher.There is important inflation data Friday when the Fed’s preferred inflation gauge is reported.The personal consumption expenditure report is expected to show a 1.8% rise in core inflation, still below the Fed’s target of 2%. Other data releases include the first-quarter gross domestic product on Thursday, which is expected to have grown by 6.5%, according to Dow Jones.“I think the Fed has no urgency to shift monetary policy at this point,” said Ian Lyngen, head of U.S. rates strategy at BMO. “The Fed needs to acknowledge that the data is improving. We had a strong first quarter.”“The Fed needs to acknowledge that but at the same time they’re keeping extremely accommodative policy in place, so they’ll have to make a note to the fact that the easy policy is warranted,” he said.Lyngen said the Fed will likely point to continued concerns about the pandemic globally as a potential risk to the economic recovery.Powell is also expected to once more explain that the Fed will let inflation rise above its 2% target for a period of time before it raises rates so that the economy can have more time to heal. “It’s going to be a challenge for the Fed,” said Swonk.The base effects for the next several months will make inflation appear to have jumped sharply because of the comparison to a weak period last year. The consumer price index for April could be above 3%, compared to 2.6% last month, Swonk added.“The Fed is trying to let a lot more people get out onto the dance floor before it calls ‘last call,’” she said. “Really what Powell has been saying since day one is if we take care of people on the margins and bring them back into the labor force, the rest will take care of itself.”Stocks were slightly lower in the past week, and Treasury yields held at lower levels. The 10-year yield,which moves opposite price, was at 1.55% Friday.The S&P 500was down 0.1%, ending the week at 4,180, while Nasdaq Composite was down nearly 0.3% at 14,016. The Dow was off just shy of 0.5% at 34,043.Tax hike prospectsStocks were hit hard on Thursday when after a news report said that Biden is expected to propose a capital gains tax rate of 39.6% for people earning more than $1 million a year.Combined with the 3.8% net investment income tax, the new levy would more than double the long term capital gains rate of 20% or the richest Americans.Strategists said Biden is expected to propose raising the income tax rate for those earning more than $400,000.“I think a lot of people are starting to price in the risk there going to be a significant increase in both corporate and capital gains taxes,” said Lyngen.So far, companies have not provided much in the way of commentary on the proposed hike in corporate taxes to 28% from 21% but they have been talking about other costs.David Bianco, chief investment strategist for the Americas at DWS, said he expects larger companies will do better dealing with supply chain constraints than smaller ones. Big Tech is also likely to fare better during the semiconductor shortage than auto makers, which have already announced production shutdowns, he said.“Next week is tech week. I think we’re going to get down on our knees and just be in awe of their business models and their ability to grow at a behemoth scale,” Bianco said.He said he’s not in favor of Wall Street’s popular trade into cyclicals and out of growth. He still favors growth.“We’re overweight equities really because we’re concerned about rising interest rates,” Bianco said. “I’m not bullish in that I expect the market to rise that much from here.”“We stuck with growth and dug deeper into bond substitutes, utilities, staples, real estate,” he said, adding he is underweight industrials, energy and materials. “Energy is doomed. It’s being nationalized via regulation. I do like industrials, they are well-run companies, but I do think infrastructure spending expectations for classic infrastructure are too high.”He also said industrials are good businesses, but the stocks have become overvalued.Bianco said he likes big box stores, but smaller retailers are facing big challenges that were already impacting them prior to Covid. He also finds small biotech firms attractive.“I like healthcare stocks. Those valuations are reasonable. People have been paranoid about politicians beating on them since 1992. They manage through it and lately they’ve been delivering,” he said.Week ahead calendarMondayEarnings:Tesla,Canadian National Railway, Canon,Check Point Software,Otis Worldwide, Vale,Ameriprise,NXP Semiconductor,Albertsons, Royal Phillips8:30 a.m. Durable goodsTuesdayFOMC begins two day meetingEarnings:Microsoft,Alphabet,Visa,Amgen,Advanced Micro Devices,3M,General Electric,Eli Lilly, Hasbro,United Parcel Service,BP,Novartis,JetBlue,Pultegroup,Archer Daniels Midland,Waste Management,Starbucks,Texas Instrument,Chubb,Mondelez,FireEye,Corning,Raytheon9:00 a.m. S&P/Case-Shiller9:00 a.m. FHFA home prices10:00 a.m. Consumer confidence10:00 a.m. Housing vacanciesWednesdayEarnings:Apple, Boeing,Facebook,Qualcomm,Ford,MGM Resorts,Humana,Norfolk Southern,General Dynamics,Boston Scientific, eBay, Samsung Electronics, GlaxoSmithKline,Yum Brands, SiriusXM, Aflac,Cheesecake Factory,Community Health System,CIT Group,Entergy,CME Group,Hess,Ryder System8:30 a.m. Advance economic indicators2:00 p.m. Fed statement2:30 p.m. Fed Chairman Jerome Powell briefingThursdayEarnings:Amazon,Caterpillar,McDonald’s,Twitter,Bristol-Myers Squibb,Comcast,Merck,Northrop Grumman, Airbus,Kraft Heinz,Intercontinental Exchange,Mastercard,Gilead Sciences,U.S. Steel, Cirrus Logic,Texas Roadhouse, Cabot Oil, PG&E,Royal Dutch Shell,Church & Dwight, Carlyle Group,Southern Co.8:30 a.m. Initial jobless claims8:30 a.m. Real GDP Q110:00 a.m. Pending home salesFridayEarnings:ExxonMobil,Chevron,Colgate-Palmolive,AstraZeneca,Clorox,Barclays, AbbVie, BNP Paribas,Weyerhaeuser,Illinois Tool Works, CBOE Global Markets, Lazard,Newell Brands,Aon,LyondellBasell,Pitney Bowes,Phillips 66,Charter Communications8:30 a.m. Personal income and spending8:30 a.m. Employment cost index Q19:45 a.m. Chicago PMI10:00 a.m. Consumer sentimentSaturdayEarnings:Berkshire Hathaway","news_type":1},"isVote":1,"tweetType":1,"viewCount":100,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345522753,"gmtCreate":1618324786272,"gmtModify":1634293696358,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Please respond, thank you!&nbsp;","listText":"Please respond, thank you!&nbsp;","text":"Please respond, thank you!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/345522753","repostId":"1117691635","repostType":4,"isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":375665070,"gmtCreate":1619334158890,"gmtModify":1634274145189,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Oh boo","listText":"Oh boo","text":"Oh boo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/375665070","repostId":"2129804364","repostType":4,"isVote":1,"tweetType":1,"viewCount":235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":347647386,"gmtCreate":1618494988745,"gmtModify":1634292550590,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Oh no! Like and reply please?&nbsp;","listText":"Oh no! Like and reply please?&nbsp;","text":"Oh no! Like and reply please?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/347647386","repostId":"1138925904","repostType":4,"isVote":1,"tweetType":1,"viewCount":325,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345567990,"gmtCreate":1618324463610,"gmtModify":1634293701996,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/345567990","repostId":"1101919556","repostType":4,"repost":{"id":"1101919556","pubTimestamp":1618320023,"share":"https://www.laohu8.com/m/news/1101919556?lang=&edition=full","pubTime":"2021-04-13 21:20","market":"us","language":"en","title":"Don’t ‘overinterpret’ decision to pause J&J Covid vaccine over rare clotting issue, Dr. Scott Gottlieb says","url":"https://stock-news.laohu8.com/highlight/detail?id=1101919556","media":"cnbc","summary":"KEY POINTS\n\nDr. Scott Gottlieb said Tuesday that people should be “cautious not to overinterpret” th","content":"<div>\n<p>KEY POINTS\n\nDr. Scott Gottlieb said Tuesday that people should be “cautious not to overinterpret” the Food and Drug Administration’s decision to temporarily halt use of Johnson & Johnson’s coronavirus...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/13/scott-gottlieb-cautions-against-overreaction-to-johnson-johnson-covid-vaccine-pause.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Don’t ‘overinterpret’ decision to pause J&J Covid vaccine over rare clotting issue, Dr. Scott Gottlieb says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDon’t ‘overinterpret’ decision to pause J&J Covid vaccine over rare clotting issue, Dr. Scott Gottlieb says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-13 21:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/04/13/scott-gottlieb-cautions-against-overreaction-to-johnson-johnson-covid-vaccine-pause.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nDr. Scott Gottlieb said Tuesday that people should be “cautious not to overinterpret” the Food and Drug Administration’s decision to temporarily halt use of Johnson & Johnson’s coronavirus...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/13/scott-gottlieb-cautions-against-overreaction-to-johnson-johnson-covid-vaccine-pause.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://www.cnbc.com/2021/04/13/scott-gottlieb-cautions-against-overreaction-to-johnson-johnson-covid-vaccine-pause.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1101919556","content_text":"KEY POINTS\n\nDr. Scott Gottlieb said Tuesday that people should be “cautious not to overinterpret” the Food and Drug Administration’s decision to temporarily halt use of Johnson & Johnson’s coronavirus vaccine.\nBut he predicted that the move will nonetheless “fuel the hesitancy” from some people to get a Covid vaccine.\n\nDr. Scott Gottlieb said Tuesday that people should be “cautious not to overinterpret” the Food and Drug Administration’sdecision to temporarily halt useofJohnson & Johnson’s coronavirus vaccine.\n“Let’s start with what the FDA didn’t do,” Gottlieb, the former FDA commissioner and current member of Pfizer’sboard of directors, said on CNBC’s “Squawk Box.” “They didn’t revoke the emergency use authorization. They didn’t order this off the market.”\n“This was a requested pause, which is an awkward regulatory step but I think it reflects the level of caution on their part to not to appear to act too forcefully here,” he said of the decision, which came after six women, out of millions vaccinated, developed blood clots.\nBut Gottlieb predicted that the move will nonetheless “fuel the hesitancy” from some people to get a Covid vaccine.\n“Even if there isn’t a causal relationship, even if this is exceedingly rare, I think we’re going to see that whole conversation now get ignited on social media,” he said.\nThe single-dose vaccine is being paused “out of an abundance of caution” after six women in the U.S. developed a rare blood clotting disorder following their vaccinations, the FDA said Tuesday morning. All of those cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot.\nNearly 7 million doses of J&J’s vaccine have been administered, making the adverse events “extremely rare,” the FDA stressed in a joint statement with the Centers for Disease Control and Prevention.\nGottlieb said that he believes the J&J vaccine could come back into use “with some additional, perhaps, restrictions on its target populations in the interim while they continue to investigate this.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":78,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":377824605,"gmtCreate":1619516646907,"gmtModify":1634212128796,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"So sad&nbsp;","listText":"So sad&nbsp;","text":"So sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/377824605","repostId":"1152045902","repostType":4,"isVote":1,"tweetType":1,"viewCount":59,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":375665854,"gmtCreate":1619334234578,"gmtModify":1634274144950,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Reply please? Thank you&nbsp;","listText":"Reply please? Thank you&nbsp;","text":"Reply please? Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/375665854","repostId":"1158817636","repostType":4,"repost":{"id":"1158817636","pubTimestamp":1619331374,"share":"https://www.laohu8.com/m/news/1158817636?lang=&edition=full","pubTime":"2021-04-25 14:16","market":"us","language":"en","title":"7 Electric Vehicle Stocks to Buy on the Dips","url":"https://stock-news.laohu8.com/highlight/detail?id=1158817636","media":"InvestorPlace","summary":"Although they're currently too expensive, these EV names have immense long-term potential. Electric vehicle  sales have seen a massive upward trajectory over the past year. Originally, the consensus was that automotive companies and electric vehicle stocks would struggle in unison during the pandemic, but that hasn’t been the case.In fact, according to the International Energy Agency, there was a slight increase in EV sales while global car sales contracted by roughly 14%. Policy support and con","content":"<p>Although they're currently too expensive, these EV names have immense long-term potential</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4a06e07857cfa0b458b4a7fb172b6a04\" tg-width=\"1024\" tg-height=\"576\"><span>Source: buffaloboy / Shutterstock.com</span></p>\n<p>Electric vehicle (EV) sales have seen a massive upward trajectory over the past year. Originally, the consensus was that automotive companies and&nbsp;electric vehicle stocks&nbsp;would struggle in unison during the pandemic, but that hasn’t been the case.</p>\n<p>In fact, according to the&nbsp;<i>International Energy Agency</i>, there was a&nbsp;slight increase&nbsp;in EV sales while global car sales&nbsp;contracted by roughly 14%. Policy support and continued reductions in battery costs as well as improvements in equipment were the main contributors to increased investor interest. Hence, electric vehicle stocks have continued to post incredible returns. But that has also led to bubble fears.</p>\n<p>Electric vehicle stocks recently sold off, which in many ways is clearing the frothiness out of the sector. However, despite the pullback, these names remain significantly overvalued compared to other areas in the market. For example, industry giant&nbsp;<b>Tesla</b>&nbsp;(NASDAQ:<b>TSLA</b>) has a forward price-to-sales (P/S) ratio of 14.02 times, which exceeds the sector average by nearly 933%.</p>\n<p>TSLA is not alone, though — several companies in its peer group have similar numbers. Therefore, it’s best to wait for the appropriate dips before investing in the most promising electric vehicle stocks. The list below covers seven of those best names which are operating in the market today.</p>\n<ul>\n <li><b>Nio</b>(NYSE:<b>NIO</b>)</li>\n <li><b>Fisker</b>(NYSE:<b>FSR</b>)</li>\n <li><b>Blink Charging</b>(NASDAQ:<b>BLNK</b>)</li>\n <li><b>Chargepoint</b>(NYSE:<b>CHPT</b>)</li>\n <li><b>Xpeng</b>(NYSE:<b>XPEV</b>)</li>\n <li><b>Li Auto</b>(NASDAQ:<b>LI</b>)</li>\n <li><b>Arrival</b>(NASDAQ:<b>ARVL</b>)</li>\n</ul>\n<p><b>Nio (NIO)</b></p>\n<p>First up on this list of electric vehicle stocks, Chinese EV maker Nio is often dubbed “the Tesla of China.” The company has shown incredible progress since its founding, following in the footsteps of the American EV pioneer it is so often compared to. Recently, the company hit&nbsp;100,000 deliveries, a feat that even Elon Musk applauded.</p>\n<p>Currently, NIO stock has an upsized market capitalization of more than $60 billion. However, as we have seen in the sector, investors are ready to pay for sustained growth. Nio has an upscale position in the EV market and makes luxury vehicles with a strong affinity for technology. Moreover, the company is well-capitalized to fund its growth efforts. As of December last year, it had a&nbsp;massive $6.5 billion&nbsp;in its cash till.</p>\n<p>Looking ahead, Nio plans to make its move into the luxury-sedan segment in order to expand its margins further and turn a profit. What’s encouraging, though, is that its gross margins and operating cash flows went positive in the past year, showing that profitability is in sight.</p>\n<p><b>Fisker (FSR)</b></p>\n<p>Fisker is one of the most intriguing names in the EV industry, with a seasoned veteran in the automotive sector at its helm: Henrik Fisker. The company has its all-electric SUV called the Ocean in development. Moreover, it has also entered into a partnership with the famous Taiwanese contracts manufacturer&nbsp;<b>Foxconn</b>&nbsp;for&nbsp;producing its EVs in 2023. Therefore, without making a single dime in revenues, FSR stock has become one of the top speculative electric vehicle stocks in the market.</p>\n<p>There are a few differentiating elements that make Fisker one of the more promising EV companies out there. Firstly, it operates an asset-light model that focuses primarily on its car design and technological abilities. Moreover, the Ocean has an attractive price point with an all-covering lease option. Finally, the company has struck a few pertinent contract, delivery and fleet management deals in Europe and North America in&nbsp;anticipation of the Ocean’s commercial release&nbsp;in 2022.</p>\n<p>It will be interesting to see how things progress, but FSR stock is looking highly attractive at this time.</p>\n<p><b>Blink Charging (BLNK)</b></p>\n<p>EV equipment charging provider Blink Charging has been one of the best-performing electric vehicle stocks in the market. As of today, BLNK stock is up a whopping 306% in the past six months. Despite the challenges posed by the pandemic, it has done exceptionally well to grow its revenues and asset base. With&nbsp;over 23,000 charging stations&nbsp;across North America, Europe, the Middle East and elsewhere, the company has cemented itself as an industry leader.</p>\n<p>Blink Charging recently reported fourth-quarter results. For Q4, revenues shot up&nbsp;roughly 250%&nbsp;on a year-over-year (YOY) basis. Moreover, it noted that its commercially deployed charging stations&nbsp;grew 51%&nbsp;YOY.</p>\n<p>Earnings performance for the full year was mighty impressive, considering the circumstances. And with the exponential growth in EVs over the next few decades or so, the need for additional charging equipment is evident. However, despite the massive growth runway ahead, BLNK stock is highly overvalued. Investors need to wait for a better entry point in this name.</p>\n<p><b>Chargepoint (CHPT)</b></p>\n<p>EV charging specialist Chargepoint recently completed its merger with shell company Switchback Energy Acquisition. Currently, Chargepoint has a dominating position in the EV charging realm with a huge&nbsp;market share of 73%&nbsp;in North America. Moreover, it plans to&nbsp;increase its revenues&nbsp;from $146.5 million last year to&nbsp;roughly $1 billion&nbsp;by 2024.</p>\n<p>CHPT stock took a hit when it announced its earnings results back in mid-March. Revenues came in slightly higher than estimates and only slightly up from 2019’s $144.5 million in revenue. However, gross margins improved to 22.6%, the brightest spot in the results. Moreover, its cash reserves increased significantly after the merger transaction.</p>\n<p>Chargepoint plans to use this cash as part of its efforts to expand its charging-station footprint. On top of that, the company’s investments in the fast-growing European market could give it an edge over other electric vehicle stocks.</p>\n<p><b>Xpeng (XPEV)</b></p>\n<p>Xpeng is among the three juggernauts of the EV space in China. It is arguably one of the fastest-growing companies in its sphere, with its YOY revenue growth at about 152%. Now, revenues are estimated to reach $2.21 billion in 2021 and $4.29 billion the following year. Moreover, Xpeng is currently building an impressive&nbsp;autonomous driving lidar systems&nbsp;in-house. As a consequence, XPEV stock is up a healthy 57% for the past six months.</p>\n<p>Xpeng’s delivery numbers for its most recent quarter were also very healthy, coming in at&nbsp;nearly 13,000&nbsp;vehicles. Despite chip shortages, the company is on track to deliver some&nbsp;57,500 units&nbsp;for the year. Xpeng has also done an incredible job in separating itself from other electric vehicle stocks in terms of technology; its flagship XPILOT software continues to be upgraded with better&nbsp;capabilities.</p>\n<p>So, with so many exciting developments in the pipeline, XPEV stock is a pick that can’t be missed on the dip.</p>\n<p><b>Li Auto (LI)</b></p>\n<p>The last Chinese EV maker on this list is Li Auto, a company that has in many ways played second fiddle to Xpeng and Nio in the domestic market. However, with its remarkable discipline in costs and margins, along with some interesting features, Li could be the first to break into profitability among its peers. Moreover, its revenues have also increased substantially in the past few quarters. That’s a testament to its solid brand equity.</p>\n<p>The company started off the year strong, with its January deliveries up more than 356% from the prior-year period. Li Auto’s total deliveries&nbsp;increased to 38,976. Looking ahead, Xpeng is also looking at a possible 70,000 deliveries this year, making for YOY growth of&nbsp;approximately 115%&nbsp;according to&nbsp;<i>Seeking Alpha</i>.</p>\n<p>That’s not all, however. Additionally, Li Auto has been investing heavily in its autonomous technology. Its partnership with&nbsp;<b>Nvidia</b>&nbsp;(NASDAQ:<b><u>NVDA</u></b>) could also&nbsp;aid delivery growth. LI stock, however, is as overbought as its peers. That’s why it would be prudent to wait for a dip before investing in this one of the electric vehicle stocks.</p>\n<p><b>Arrival (ARVL)</b></p>\n<p>United Kingdom-based EV startup Arrival has been getting a lot of traction this year among the electric vehicle stocks. The company specializes in EV bus and van production and recently completed its merger with blank-check company CIIG Merger.</p>\n<p>This merger helped Arrival raise&nbsp;$660 million&nbsp;in proceeds. What’s more, although it has entered a crowded space, Arrival’s decentralized manufacturing model is also poised to give it greater flexibility and a quicker path toward commercial production. This makes the company disruptive.</p>\n<p>Arrival expects to begin commercial production in the coming two years. However, one of its customers —<b>United Parcel Service</b>&nbsp;(NYSE:<b><u>UPS</u></b>) — has already ordered&nbsp;10,000 of its EVs, which the company will produce through its “microfactories.”</p>\n<p>All in all, ARVL stock could become a significant player in the EV space based on its current progression and unique production model. That makes this a name that EV investors should definitely consider.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Electric Vehicle Stocks to Buy on the Dips</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Electric Vehicle Stocks to Buy on the Dips\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 14:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/seven-electric-vehicle-stocks-buy-on-dips/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Although they're currently too expensive, these EV names have immense long-term potential\nSource: buffaloboy / Shutterstock.com\nElectric vehicle (EV) sales have seen a massive upward trajectory over ...</p>\n\n<a href=\"https://investorplace.com/2021/04/seven-electric-vehicle-stocks-buy-on-dips/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CHPT":"ChargePoint Holdings Inc.","XPEV":"小鹏汽车","BLNK":"Blink Charging","LI":"理想汽车","FSR":"菲斯克","NIO":"蔚来"},"source_url":"https://investorplace.com/2021/04/seven-electric-vehicle-stocks-buy-on-dips/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158817636","content_text":"Although they're currently too expensive, these EV names have immense long-term potential\nSource: buffaloboy / Shutterstock.com\nElectric vehicle (EV) sales have seen a massive upward trajectory over the past year. Originally, the consensus was that automotive companies and electric vehicle stocks would struggle in unison during the pandemic, but that hasn’t been the case.\nIn fact, according to the International Energy Agency, there was a slight increase in EV sales while global car sales contracted by roughly 14%. Policy support and continued reductions in battery costs as well as improvements in equipment were the main contributors to increased investor interest. Hence, electric vehicle stocks have continued to post incredible returns. But that has also led to bubble fears.\nElectric vehicle stocks recently sold off, which in many ways is clearing the frothiness out of the sector. However, despite the pullback, these names remain significantly overvalued compared to other areas in the market. For example, industry giant Tesla (NASDAQ:TSLA) has a forward price-to-sales (P/S) ratio of 14.02 times, which exceeds the sector average by nearly 933%.\nTSLA is not alone, though — several companies in its peer group have similar numbers. Therefore, it’s best to wait for the appropriate dips before investing in the most promising electric vehicle stocks. The list below covers seven of those best names which are operating in the market today.\n\nNio(NYSE:NIO)\nFisker(NYSE:FSR)\nBlink Charging(NASDAQ:BLNK)\nChargepoint(NYSE:CHPT)\nXpeng(NYSE:XPEV)\nLi Auto(NASDAQ:LI)\nArrival(NASDAQ:ARVL)\n\nNio (NIO)\nFirst up on this list of electric vehicle stocks, Chinese EV maker Nio is often dubbed “the Tesla of China.” The company has shown incredible progress since its founding, following in the footsteps of the American EV pioneer it is so often compared to. Recently, the company hit 100,000 deliveries, a feat that even Elon Musk applauded.\nCurrently, NIO stock has an upsized market capitalization of more than $60 billion. However, as we have seen in the sector, investors are ready to pay for sustained growth. Nio has an upscale position in the EV market and makes luxury vehicles with a strong affinity for technology. Moreover, the company is well-capitalized to fund its growth efforts. As of December last year, it had a massive $6.5 billion in its cash till.\nLooking ahead, Nio plans to make its move into the luxury-sedan segment in order to expand its margins further and turn a profit. What’s encouraging, though, is that its gross margins and operating cash flows went positive in the past year, showing that profitability is in sight.\nFisker (FSR)\nFisker is one of the most intriguing names in the EV industry, with a seasoned veteran in the automotive sector at its helm: Henrik Fisker. The company has its all-electric SUV called the Ocean in development. Moreover, it has also entered into a partnership with the famous Taiwanese contracts manufacturer Foxconn for producing its EVs in 2023. Therefore, without making a single dime in revenues, FSR stock has become one of the top speculative electric vehicle stocks in the market.\nThere are a few differentiating elements that make Fisker one of the more promising EV companies out there. Firstly, it operates an asset-light model that focuses primarily on its car design and technological abilities. Moreover, the Ocean has an attractive price point with an all-covering lease option. Finally, the company has struck a few pertinent contract, delivery and fleet management deals in Europe and North America in anticipation of the Ocean’s commercial release in 2022.\nIt will be interesting to see how things progress, but FSR stock is looking highly attractive at this time.\nBlink Charging (BLNK)\nEV equipment charging provider Blink Charging has been one of the best-performing electric vehicle stocks in the market. As of today, BLNK stock is up a whopping 306% in the past six months. Despite the challenges posed by the pandemic, it has done exceptionally well to grow its revenues and asset base. With over 23,000 charging stations across North America, Europe, the Middle East and elsewhere, the company has cemented itself as an industry leader.\nBlink Charging recently reported fourth-quarter results. For Q4, revenues shot up roughly 250% on a year-over-year (YOY) basis. Moreover, it noted that its commercially deployed charging stations grew 51% YOY.\nEarnings performance for the full year was mighty impressive, considering the circumstances. And with the exponential growth in EVs over the next few decades or so, the need for additional charging equipment is evident. However, despite the massive growth runway ahead, BLNK stock is highly overvalued. Investors need to wait for a better entry point in this name.\nChargepoint (CHPT)\nEV charging specialist Chargepoint recently completed its merger with shell company Switchback Energy Acquisition. Currently, Chargepoint has a dominating position in the EV charging realm with a huge market share of 73% in North America. Moreover, it plans to increase its revenues from $146.5 million last year to roughly $1 billion by 2024.\nCHPT stock took a hit when it announced its earnings results back in mid-March. Revenues came in slightly higher than estimates and only slightly up from 2019’s $144.5 million in revenue. However, gross margins improved to 22.6%, the brightest spot in the results. Moreover, its cash reserves increased significantly after the merger transaction.\nChargepoint plans to use this cash as part of its efforts to expand its charging-station footprint. On top of that, the company’s investments in the fast-growing European market could give it an edge over other electric vehicle stocks.\nXpeng (XPEV)\nXpeng is among the three juggernauts of the EV space in China. It is arguably one of the fastest-growing companies in its sphere, with its YOY revenue growth at about 152%. Now, revenues are estimated to reach $2.21 billion in 2021 and $4.29 billion the following year. Moreover, Xpeng is currently building an impressive autonomous driving lidar systems in-house. As a consequence, XPEV stock is up a healthy 57% for the past six months.\nXpeng’s delivery numbers for its most recent quarter were also very healthy, coming in at nearly 13,000 vehicles. Despite chip shortages, the company is on track to deliver some 57,500 units for the year. Xpeng has also done an incredible job in separating itself from other electric vehicle stocks in terms of technology; its flagship XPILOT software continues to be upgraded with better capabilities.\nSo, with so many exciting developments in the pipeline, XPEV stock is a pick that can’t be missed on the dip.\nLi Auto (LI)\nThe last Chinese EV maker on this list is Li Auto, a company that has in many ways played second fiddle to Xpeng and Nio in the domestic market. However, with its remarkable discipline in costs and margins, along with some interesting features, Li could be the first to break into profitability among its peers. Moreover, its revenues have also increased substantially in the past few quarters. That’s a testament to its solid brand equity.\nThe company started off the year strong, with its January deliveries up more than 356% from the prior-year period. Li Auto’s total deliveries increased to 38,976. Looking ahead, Xpeng is also looking at a possible 70,000 deliveries this year, making for YOY growth of approximately 115% according to Seeking Alpha.\nThat’s not all, however. Additionally, Li Auto has been investing heavily in its autonomous technology. Its partnership with Nvidia (NASDAQ:NVDA) could also aid delivery growth. LI stock, however, is as overbought as its peers. That’s why it would be prudent to wait for a dip before investing in this one of the electric vehicle stocks.\nArrival (ARVL)\nUnited Kingdom-based EV startup Arrival has been getting a lot of traction this year among the electric vehicle stocks. The company specializes in EV bus and van production and recently completed its merger with blank-check company CIIG Merger.\nThis merger helped Arrival raise $660 million in proceeds. What’s more, although it has entered a crowded space, Arrival’s decentralized manufacturing model is also poised to give it greater flexibility and a quicker path toward commercial production. This makes the company disruptive.\nArrival expects to begin commercial production in the coming two years. However, one of its customers —United Parcel Service (NYSE:UPS) — has already ordered 10,000 of its EVs, which the company will produce through its “microfactories.”\nAll in all, ARVL stock could become a significant player in the EV space based on its current progression and unique production model. That makes this a name that EV investors should definitely consider.","news_type":1},"isVote":1,"tweetType":1,"viewCount":157,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345564314,"gmtCreate":1618324414838,"gmtModify":1634293702824,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/345564314","repostId":"2127274015","repostType":4,"isVote":1,"tweetType":1,"viewCount":435,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":345522000,"gmtCreate":1618324736300,"gmtModify":1634293696935,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Yes!&nbsp;","listText":"Yes!&nbsp;","text":"Yes!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/345522000","repostId":"1117691635","repostType":4,"isVote":1,"tweetType":1,"viewCount":84,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345528581,"gmtCreate":1618324702243,"gmtModify":1634293697982,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"Wow cool!&nbsp;","listText":"Wow cool!&nbsp;","text":"Wow cool!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/345528581","repostId":"1117691635","repostType":4,"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345523018,"gmtCreate":1618324616334,"gmtModify":1634293700318,"author":{"id":"3579093685551005","authorId":"3579093685551005","authorIdStr":"3579093685551005","name":"KittyCara","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579093685551005"},"themes":[],"htmlText":"[呆住]&nbsp;","listText":"[呆住]&nbsp;","text":"[呆住]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/345523018","repostId":"2127274015","repostType":4,"isVote":1,"tweetType":1,"viewCount":548,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}